Page last updated: 2024-08-26

mafosfamide and etoposide

mafosfamide has been researched along with etoposide in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19903 (30.00)18.7374
1990's6 (60.00)18.2507
2000's1 (10.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fox, RM; Marks, DI1
Garssen, J; Limpens, J; Scheper, RJ1
Garssen, J; Germeraad, WT; Limpens, J; Scheper, RJ1
Hervé, P; Tamayo, E1
Linch, DC; Singer, CR1
Cantori, I; Corvatta, L; Curzi, L; Leoni, P; Mancini, S; Masia, MC; Montanari, M; Olivieri, A; Poloni, A1
Campanini, E; Fogli, M; Fortuna, A; Lemoli, RM; Mangianti, S; Motta, MR; Ratta, M; Rizzi, S; Tura, S1
Andreu, G; Aoudjhane, M; Bauters, F; Belkacemi, Y; Cheron, N; Douay, L; Fenaux, P; Fouillard, L; Gorin, NC; Isnard, F; Jouet, JP; Labopin, M; Laporte, JP; Lemonnier, MP; Lesage, S; Lopez, M; Morel, P; Najman, A; Noël-Walter, MP; Stachowiak, J; Zunic, P1
Limpens, J; Scheper, RJ1
Czech, T; Dieckmann, K; Dietrich, W; Falger, J; Günes, M; Hainfellner, J; Pillwein, K; Prayer, D; Rössler, K; Schuller, E; Slavc, I1

Trials

1 trial(s) available for mafosfamide and etoposide

ArticleYear
Feasibility of long-term intraventricular therapy with mafosfamide (n = 26) and etoposide (n = 11): experience in 26 children with disseminated malignant brain tumors.
    Journal of neuro-oncology, 2003, Volume: 64, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Headache; Humans; Injections, Intraventricular; Injections, Spinal; Male; Meningeal Neoplasms; Nausea; Pain; Treatment Outcome

2003

Other Studies

9 other study(ies) available for mafosfamide and etoposide

ArticleYear
DNA damage, poly (ADP-ribosyl)ation and apoptotic cell death as a potential common pathway of cytotoxic drug action.
    Biochemical pharmacology, 1991, Oct-24, Volume: 42, Issue:10

    Topics: Adenosine Triphosphate; Biotransformation; Cell Death; Cell Division; Cyclophosphamide; DNA Damage; Etoposide; Humans; NAD; Poly(ADP-ribose) Polymerases; Time Factors; Tumor Cells, Cultured

1991
Local administration of cytostatic drugs enhances delayed-type hypersensitivity to Sendai virus in mice.
    Clinical immunology and immunopathology, 1990, Volume: 54, Issue:1

    Topics: Adjuvants, Immunologic; Animals; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Female; Hypersensitivity, Delayed; Mice; Mice, Inbred BALB C; Parainfluenza Virus 1, Human

1990
Enhancing effects of locally administered cytostatic drugs on T effector cell functions in mice.
    International journal of immunopharmacology, 1990, Volume: 12, Issue:1

    Topics: Animals; Antineoplastic Agents; Cell Division; Cell Migration Inhibition; Cyclophosphamide; Etoposide; Female; Hemocyanins; Hypersensitivity, Delayed; Immunity, Cellular; Interleukin-2; Lymph Nodes; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; T-Lymphocytes

1990
Preclinical studies of the combination of mafosfamide (Asta-Z 7654) and etoposide (VP-16-213) for purging leukemic autologous marrow.
    Experimental hematology, 1988, Volume: 16, Issue:2

    Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Transplantation; Cell Line; Cells, Cultured; Colony-Forming Units Assay; Cyclophosphamide; Etoposide; Humans; Leukemia; Lymphocyte Activation; Time Factors; Transplantation, Autologous

1988
Comparison of the sensitivity of normal and leukaemic myeloid progenitors to in-vitro incubation with cytotoxic drugs: a study of pharmacological purging.
    Leukemia research, 1987, Volume: 11, Issue:11

    Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Transplantation; Cell Survival; Clone Cells; Cyclophosphamide; Cytarabine; Etoposide; Granulocytes; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Melphalan; Transplantation, Autologous; Tumor Cells, Cultured

1987
Pharmacologic bone marrow purging: is there any place for etoposide? In vitro comparison with mafosfamide.
    Journal of hematotherapy, 1997, Volume: 6, Issue:2

    Topics: Antineoplastic Agents; Bone Marrow Purging; Coculture Techniques; Colony-Forming Units Assay; Cyclophosphamide; Etoposide; Hematopoietic Stem Cells; Humans; Leukemia, Erythroblastic, Acute; Tumor Cells, Cultured

1997
Pharmacological purging of minimal residual disease from peripheral blood stem cell collections of acute myeloblastic leukemia patients: preclinical studies.
    Experimental hematology, 1997, Volume: 25, Issue:12

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Cyclophosphamide; Etoposide; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Mechlorethamine; Neoplasm, Residual; Tumor Cells, Cultured

1997
Autologous stem-cell transplantation for non-Hodgkin's lymphomas: the role of graft purging and radiotherapy posttransplantation--results of a retrospective analysis on 120 patients autografted in a single institution.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Prognosis; Recurrence; Remission Induction; Retrospective Studies

1998
Synergistic effects of locally administered cytostatic drugs and a surfactant on the development of delayed-type hypersensitivity to keyhole limpet haemocyanin in mice.
    Clinical and experimental immunology, 1989, Volume: 78, Issue:2

    Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Cyclophosphamide; Drug Synergism; Etoposide; Hemocyanins; Hypersensitivity, Delayed; Immunization; Male; Mice; Mice, Inbred BALB C; Quaternary Ammonium Compounds; Surface-Active Agents

1989